ChemMedChem

Cover image for Vol. 11 Issue 14

Editorial Board Chairs: Antonello Mai, Rainer Metternich. Assoc. Editors: David Peralta, Scott Williams (Sr)

Impact Factor: 2.98

ISI Journal Citation Reports © Ranking: 2015: 18/59 (Chemistry Medicinal); 76/253 (Pharmacology & Pharmacy)

Online ISSN: 1860-7187

Associated Title(s): Angewandte Chemie International Edition, Chemistry - A European Journal, Chemistry – An Asian Journal, ChemBioChem, Medicinal Research Reviews, Molecular Informatics

Recently Published Issues

See all

Latest News

Browse more news

July 24, 2016

Drugs to Fight Bugs

Drugs to Fight BugsTwo recent reports in ChemMedChem are making waves in antimicrobial research. In the early July issue (13), professors William Wuest (Temple University), Kevin Minbiole (Villanova University), and co-workers report branched tetracationic quaternary ammonium compounds (QACs) as the most potent QACs reported so far against methicillin-resistant S. aureus. Their work is a significant breakthrough in the field of antiseptics and anti-biofilm agents.

In the current issue (14), Prof. R. D. Süssmuth and colleagues at the Technische Universität Berlin report their study of highly potent albicidin derivatives which will aid in the development of more drug-like structures of this class of antibiotic.

Your Comment...

[Browse more news]

Recently Published Articles

  1. 2-Anilino-3-Aroylquinolines as Potent Tubulin Polymerization Inhibitors

    P. S. Srikanth, V. Lakshma Nayak, Korrapati Suresh Babu, G. Bharath Kumar, A. Ravikumar and Dr. Ahmed Kamal

    Version of Record online: 28 JUL 2016 | DOI: 10.1002/cmdc.201600259

    Thumbnail image of graphical abstract

    A red light for cell division: A new series of 2-anilino-3-aroylquinolines were synthesized and evaluated for their anticancer activity. Tubulin polymerization assays, western blot analyses, Annexin V–FITC assays, analysis of intracellular ROS generation, and immunohistochemistry data indicate that these compounds effectively disrupt tubulin polymerization by interacting with the colchicine binding site of tubulin.

  2. BODIPY-Appended 2-(2-Pyridyl)benzimidazole Platinum(II) Catecholates for Mitochondria-Targeted Photocytotoxicity

    Dr. Koushambi Mitra, Srishti Gautam, Prof. Paturu Kondaiah and Prof. Akhil R. Chakravarty

    Version of Record online: 28 JUL 2016 | DOI: 10.1002/cmdc.201600320

    Thumbnail image of graphical abstract

    Light on target: Platinum(II) catecholates with 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY)-appended pyridylbenzimidazole ligands specifically target mitochondria. The complexes exhibit remarkable photocytotoxicity in visible light in HaCaT cells by causing apoptotic cell death through singlet oxygen species, yet they are non-toxic in the dark. The emisssive BODIPY complex was used for cellular imaging, whereas the diiodo-BODIPY analogue showed remarkable photodynamic therapy effects.

  3. Structure, Function, and Inhibition of Staphylococcus aureus Heptaprenyl Diphosphate Synthase

    Janish Desai, Dr. Yi-Liang Liu, Hongli Wei, Dr. Weidong Liu, Dr. Tzu-Ping Ko, Prof. Rey-Ting Guo and Prof. Eric Oldfield

    Version of Record online: 26 JUL 2016 | DOI: 10.1002/cmdc.201600311

    Thumbnail image of graphical abstract

    New drug target: Staphylococcus aureus heptaprenyl diphosphate synthase (HepPPS), involved in menaquinone biosynthesis, functions as a heterodimer and is inhibited by bisphosphonates (IC50=0.83 μm), which also inhibit S. aureus cell growth, an effect that is rescued by menaquinone. HepPPS is also partially inhibited by its substrates FPP as well as IPP, most likely due to disruption of the heterodimeric complex structure.

  4. You have full text access to this OnlineOpen article
    Chemical Platform for the Preparation of Synthetic Orally Active Peptidomimetics with Hemoregulating Activity

    Prof. Vladislav Deigin, Dr. Olga Ksenofontova, Dr. Alexey Khrushchev, Dr. Oleg Yatskin, Dr. Alexandra Goryacheva and Prof. Vadim Ivanov

    Version of Record online: 26 JUL 2016 | DOI: 10.1002/cmdc.201600157

    Thumbnail image of graphical abstract

    Robust and bioavailable! The low stability of peptide pharmaceuticals in non-invasive administration limits the use of these compounds in medical practice. We developed a platform based on branched piperazine-2,5-diones for creating orally stable peptidomimetics. These derivatives were attached to the N or C termini of an active linear peptide, increasing their resistance against proteolytic activity. As a result, the first orally active hemostimulatory peptides have been prepared.

  5. Multicomponent Petasis-borono Mannich Preparation of Alkylaminophenols and Antimicrobial Activity Studies

    Íris Neto, Joana Andrade, Prof. A. S. Fernandes, Catarina Pinto Reis, Jagadish K. Salunke, Prof. Arri Priimagi, Prof. Nuno R. Candeias and Prof. Patrícia Rijo

    Version of Record online: 26 JUL 2016 | DOI: 10.1002/cmdc.201600244

    Thumbnail image of graphical abstract

    Antibiotics by MCR: We disclose a new family of antibacterial agents derived from para-nitrophenols and indoline, prepared by a multicomponent reaction (MCR). The new alkylaminophenols show minimum inhibitory concentrations lower than 1.4 μm against selected resistant microorganisms. Cytotoxicity assays demonstrated that such compounds are viable candidates as antibacterials, as no cytotoxicity was observed at these concentrations.

SEARCH

SEARCH BY CITATION